Cross-Sectional Survey of High-Risk Pregnant Women's Opinions on COVID-19 Vaccination

Marcia DesJardin, Edward Raff, Nicholas Baranco, Dimitrios MastrogiannisWomen 2022 · DOI

TL;DR

This study surveyed high-risk pregnant women in central New York about their opinions on COVID-19 vaccination, finding a vaccination rate of 38.2%. The primary barrier to vaccination was a perceived lack of data regarding its safety in pregnancy, highlighting the critical role of provider-initiated conversations during prenatal care to improve vaccine uptake.

What Problem Does This Paper Address?

The COVID-19 pandemic has posed significant risks to pregnant individuals, who are more susceptible to severe illness, hospitalization, and death from the virus. Despite strong recommendations from major obstetric and gynecological organizations for COVID-19 vaccination in pregnant women, hesitancy remains a significant issue. This is partly due to pregnant women being excluded from initial vaccine trials, leading to a reliance on observational data and a general sense of uncertainty, exacerbated by politicization. This study aims to understand the specific opinions and concerns of a high-risk pregnant population regarding COVID-19 vaccination to identify barriers and potential solutions.

Methods

The researchers conducted a cross-sectional survey of 157 high-risk pregnant patients attending a regional Maternal-Fetal Medicine clinic in central New York. Participants were invited to complete a standardized questionnaire about their COVID-19 vaccine opinions and demographic information. Additional obstetrical and medical data were abstracted from their medical records. The study employed a hierarchical Bayesian logistic regression model to analyze the data, controlling for multiple variables simultaneously to identify factors associated with vaccination status.

Datasets

The study utilized data collected from 157 pregnant women who participated in the survey. Demographic, obstetrical, and medical information was abstracted from their electronic medical records. The survey itself was modeled after questionnaires used by the Kaiser Family Foundation for national general population trends on COVID-19 vaccination hesitancy. No new benchmark datasets were introduced.

Key Insights and Ideas

  • "Lack of data in pregnancy" is the primary driver of hesitancy: This is a recurring theme, suggesting that even with growing real-world data, the initial exclusion of pregnant women from trials continues to fuel concerns.
  • Provider conversation is key: A significant majority of both vaccinated and unvaccinated participants preferred to learn about vaccines through discussions with their doctor, underscoring the importance of direct, trusted medical advice.
  • Education matters, but not in the way one might expect: While less formal education was associated with lower vaccination rates, the study suggests this might be linked to how individuals access and process information, rather than a direct rejection of medical advice.
  • COVID-19 vaccine hesitancy is not universal across vaccine types: The study found no correlation between COVID-19 vaccination status and influenza or Tdap vaccination rates, indicating that concerns are specific to the COVID-19 vaccine.

Key Results

  • Vaccination Rate: 38.2% of the surveyed high-risk pregnant women were vaccinated against COVID-19.
  • Barriers to Vaccination: The most common reason cited for vaccine hesitancy was "lack of data in pregnancy" (66% of unvaccinated participants).
  • Information Preferences: The preferred method for learning about vaccines was a conversation with their doctor (46.7% for vaccinated and 59.8% for unvaccinated).
  • Demographic Differences: No significant differences in vaccination rates were found based on race/ethnicity, living situation, marital status, employment status, insurance type, BMI, history of recreational drug use, or gestational age.
  • Education Impact: Patients with less formal education were less likely to be vaccinated.
  • Comorbidity Impact: Diabetes mellitus was the only medical comorbidity associated with a higher vaccination rate.

Limitations and Future Work

The authors acknowledge several limitations:

  • Small Sample Size and Timeframe: The study was conducted over a limited period due to staff availability, resulting in a small sample size.
  • Convenience Sampling: Patients were invited if a research staff member was present, introducing potential selection bias.
  • Language Barrier: The survey was only available in English, limiting generalizability to non-English speaking populations.
  • Technology Barrier: The survey was administered via tablet, which might underrepresent individuals uncomfortable with technology.
  • Social Desirability Bias: The presence of a staff member could have influenced responses.
  • Recall Bias: The survey was not administered at the time of potential vaccination.
  • Berkson Bias: Targeting a high-risk clinic population may not reflect the general pregnant population.

Future work could involve following up with patients to assess changes in opinions over time, evaluating the impact of interventions like provider education, and exploring the influence of political elements on vaccination decisions.

Summary updated

Abstract

The vaccination rate is low in our population. A provider-initiated conversation about COVID-19 vaccination included with routine prenatal care could increase the vaccination rate.
BibTeX
@inproceedings{desjardin2022cross,
  author = {Marcia DesJardin and Edward Raff and Nicholas Baranco and Dimitrios Mastrogiannis},
  title = {{Cross-Sectional Survey of High-Risk Pregnant Women's Opinions on COVID-19 Vaccination}},
  booktitle = {Women},
  year = {2022},
  doi = {10.1089/whr.2022.0006},
}
Figure